Injectable Contraceptives Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Injectable Contraceptives Market
1.1. Definition and Scope
1.1.1. Definition of Injectable Contraceptives
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Injectable Contraceptives Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Injectable Contraceptives Market By Type
1.2.3. Injectable Contraceptives Market By Age Group
1.2.4. Injectable Contraceptives Market By Duration of Action
1.2.5. Injectable Contraceptives Market By End-User
1.2.6. Injectable Contraceptives Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Injectable Contraceptives Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Injectable Contraceptives Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Material
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Injectable Contraceptives Market By Type
5.1. Introduction
5.2. Injectable Contraceptives Revenue By Type
5.2.1. Injectable Contraceptives Revenue (USD Billion) and Forecast, By Type, 2020-2032
5.2.2. Progesterone-only injectables
5.2.2.1. Progesterone-only Injectables Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.2. Norethisterone enanthate
5.2.2.2.1. Norethisterone Enanthate Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.2.3. Depot medroxyprogesterone acetate
5.2.2.3.1. Depot Medroxyprogesterone Acetate Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Combined injectable contraceptives
5.2.3.1. Combined Injectable Contraceptives Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Injectable Contraceptives Market By Age Group
6.1. Introduction
6.2. Injectable Contraceptives Revenue By Age Group
6.2.1. Injectable Contraceptives Revenue (USD Billion) and Forecast, By Age Group, 2020-2032
6.2.2. 15–24 years
6.2.2.1. 15–24 years Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. 25–34 years
6.2.3.1. 25–34 years Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. 35–44 years
6.2.4.1. 35–44 years Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.5. Above 44 years
6.2.5.1. Above 44 years Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Injectable Contraceptives Market By Duration of Action
7.1. Introduction
7.2. Injectable Contraceptives Revenue By Duration of Action
7.2.1. Injectable Contraceptives Revenue (USD Billion) and Forecast, By Duration of Action, 2020-2032
7.2.2. Short-acting
7.2.2.1. Short-acting Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Long-acting
7.2.3.1. Long-acting Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. Injectable Contraceptives Market By End-User
8.1. Introduction
8.2. Injectable Contraceptives Revenue By End-User
8.2.1. Injectable Contraceptives Revenue (USD Billion) and Forecast, By End-User, 2020-2032
8.2.2. Gynecology Clinics
8.2.2.1. Gynecology Clinics Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.3. Hospital
8.2.3.1. Hospital Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.4. Others
8.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Injectable Contraceptives Market By Country
9.1. North America Injectable Contraceptives Market Overview
9.2. U.S.
9.2.1. U.S. Injectable Contraceptives Revenue (USD Billion) and Forecast By Type, 2020-2032
9.2.2. U.S. Injectable Contraceptives Revenue (USD Billion) and Forecast By Age Group, 2020-2032
9.2.3. U.S. Injectable Contraceptives Revenue (USD Billion) and Forecast By Duration of Action, 2020-2032
9.2.4. U.S. Injectable Contraceptives Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.3. Canada
9.3.1. Canada Injectable Contraceptives Revenue (USD Billion) and Forecast By Type, 2020-2032
9.3.2. Canada Injectable Contraceptives Revenue (USD Billion) and Forecast By Age Group, 2020-2032
9.3.3. Canada Injectable Contraceptives Revenue (USD Billion) and Forecast By Duration of Action, 2020-2032
9.3.4. Canada Injectable Contraceptives Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Injectable Contraceptives Market By Country
10.1. Europe Injectable Contraceptives Market Overview
10.2. U.K.
10.2.1. U.K. Injectable Contraceptives Revenue (USD Billion) and Forecast By Type, 2020-2032
10.2.2. U.K. Injectable Contraceptives Revenue (USD Billion) and Forecast By Age Group, 2020-2032
10.2.3. U.K. Injectable Contraceptives Revenue (USD Billion) and Forecast By Duration of Action, 2020-2032
10.2.4. U.K. Injectable Contraceptives Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.3. Germany
10.3.1. Germany Injectable Contraceptives Revenue (USD Billion) and Forecast By Type, 2020-2032
10.3.2. Germany Injectable Contraceptives Revenue (USD Billion) and Forecast By Age Group, 2020-2032
10.3.3. Germany Injectable Contraceptives Revenue (USD Billion) and Forecast By Duration of Action, 2020-2032
10.3.4. Germany Injectable Contraceptives Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.4. France
10.4.1. France Injectable Contraceptives Revenue (USD Billion) and Forecast By Type, 2020-2032
10.4.2. France Injectable Contraceptives Revenue (USD Billion) and Forecast By Age Group, 2020-2032
10.4.3. France Injectable Contraceptives Revenue (USD Billion) and Forecast By Duration of Action, 2020-2032
10.4.4. France Injectable Contraceptives Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.5. Spain
10.5.1. Spain Injectable Contraceptives Revenue (USD Billion) and Forecast By Type, 2020-2032
10.5.2. Spain Injectable Contraceptives Revenue (USD Billion) and Forecast By Age Group, 2020-2032
10.5.3. Spain Injectable Contraceptives Revenue (USD Billion) and Forecast By Duration of Action, 2020-2032
10.5.4. Spain Injectable Contraceptives Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Injectable Contraceptives Revenue (USD Billion) and Forecast By Type, 2020-2032
10.6.2. Rest of Europe Injectable Contraceptives Revenue (USD Billion) and Forecast By Age Group, 2020-2032
10.6.3. Rest of Europe Injectable Contraceptives Revenue (USD Billion) and Forecast By Duration of Action, 2020-2032
10.6.4. Rest of Europe Injectable Contraceptives Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Injectable Contraceptives Market By Country
11.1. Asia Pacific Injectable Contraceptives Market Overview
11.2. China
11.2.1. China Injectable Contraceptives Revenue (USD Billion) and Forecast By Type, 2020-2032
11.2.2. China Injectable Contraceptives Revenue (USD Billion) and Forecast By Age Group, 2020-2032
11.2.3. China Injectable Contraceptives Revenue (USD Billion) and Forecast By Duration of Action, 2020-2032
11.2.4. China Injectable Contraceptives Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.3. Japan
11.3.1. Japan Injectable Contraceptives Revenue (USD Billion) and Forecast By Type, 2020-2032
11.3.2. Japan Injectable Contraceptives Revenue (USD Billion) and Forecast By Age Group, 2020-2032
11.3.3. Japan Injectable Contraceptives Revenue (USD Billion) and Forecast By Duration of Action, 2020-2032
11.3.4. Japan Injectable Contraceptives Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.4. India
11.4.1. India Injectable Contraceptives Revenue (USD Billion) and Forecast By Type, 2020-2032
11.4.2. India Injectable Contraceptives Revenue (USD Billion) and Forecast By Age Group, 2020-2032
11.4.3. India Injectable Contraceptives Revenue (USD Billion) and Forecast By Duration of Action, 2020-2032
11.4.4. India Injectable Contraceptives Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.5. Australia
11.5.1. Australia Injectable Contraceptives Revenue (USD Billion) and Forecast By Type, 2020-2032
11.5.2. Australia Injectable Contraceptives Revenue (USD Billion) and Forecast By Age Group, 2020-2032
11.5.3. Australia Injectable Contraceptives Revenue (USD Billion) and Forecast By Duration of Action, 2020-2032
11.5.4. Australia Injectable Contraceptives Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.6. South Korea
11.6.1. South Korea Injectable Contraceptives Revenue (USD Billion) and Forecast By Type, 2020-2032
11.6.2. South Korea Injectable Contraceptives Revenue (USD Billion) and Forecast By Age Group, 2020-2032
11.6.3. South Korea Injectable Contraceptives Revenue (USD Billion) and Forecast By Duration of Action, 2020-2032
11.6.4. South Korea Injectable Contraceptives Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Injectable Contraceptives Revenue (USD Billion) and Forecast By Type, 2020-2032
11.7.2. Rest of Asia-Pacific Injectable Contraceptives Revenue (USD Billion) and Forecast By Age Group, 2020-2032
11.7.3. Rest of Asia-Pacific Injectable Contraceptives Revenue (USD Billion) and Forecast By Duration of Action, 2020-2032
11.7.4. Rest of Asia-Pacific Injectable Contraceptives Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Injectable Contraceptives Market By Country
12.1. Latin America Injectable Contraceptives Market Overview
12.2. Brazil
12.2.1. Brazil Injectable Contraceptives Revenue (USD Billion) and Forecast By Type, 2020-2032
12.2.2. Brazil Injectable Contraceptives Revenue (USD Billion) and Forecast By Age Group, 2020-2032
12.2.3. Brazil Injectable Contraceptives Revenue (USD Billion) and Forecast By Duration of Action, 2020-2032
12.2.4. Brazil Injectable Contraceptives Revenue (USD Billion) and Forecast By End-User, 2020-2032
12.3. Mexico
12.3.1. Mexico Injectable Contraceptives Revenue (USD Billion) and Forecast By Type, 2020-2032
12.3.2. Mexico Injectable Contraceptives Revenue (USD Billion) and Forecast By Age Group, 2020-2032
12.3.3. Mexico Injectable Contraceptives Revenue (USD Billion) and Forecast By Duration of Action, 2020-2032
12.3.4. Mexico Injectable Contraceptives Revenue (USD Billion) and Forecast By End-User, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Injectable Contraceptives Revenue (USD Billion) and Forecast By Type, 2020-2032
12.4.2. Rest of Latin America Injectable Contraceptives Revenue (USD Billion) and Forecast By Age Group, 2020-2032
12.4.3. Rest of Latin America Injectable Contraceptives Revenue (USD Billion) and Forecast By Duration of Action, 2020-2032
12.4.4. Rest of Latin America Injectable Contraceptives Revenue (USD Billion) and Forecast By End-User, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Injectable Contraceptives Market By Country
13.1. Middle East & Africa Injectable Contraceptives Market Overview
13.2. GCC
13.2.1. GCC Injectable Contraceptives Revenue (USD Billion) and Forecast By Type, 2020-2032
13.2.2. GCC Injectable Contraceptives Revenue (USD Billion) and Forecast By Age Group, 2020-2032
13.2.3. GCC Injectable Contraceptives Revenue (USD Billion) and Forecast By Duration of Action, 2020-2032
13.2.4. GCC Injectable Contraceptives Revenue (USD Billion) and Forecast By End-User, 2020-2032
13.3. South Africa
13.3.1. South Africa Injectable Contraceptives Revenue (USD Billion) and Forecast By Type, 2020-2032
13.3.2. South Africa Injectable Contraceptives Revenue (USD Billion) and Forecast By Age Group, 2020-2032
13.3.3. South Africa Injectable Contraceptives Revenue (USD Billion) and Forecast By Duration of Action, 2020-2032
13.3.4. South Africa Injectable Contraceptives Revenue (USD Billion) and Forecast By End-User, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Injectable Contraceptives Revenue (USD Billion) and Forecast By Type, 2020-2032
13.4.2. Rest of Middle East & Africa Injectable Contraceptives Revenue (USD Billion) and Forecast By Age Group, 2020-2032
13.4.3. Rest of Middle East & Africa Injectable Contraceptives Revenue (USD Billion) and Forecast By Duration of Action, 2020-2032
13.4.4. Rest of Middle East & Africa Injectable Contraceptives Revenue (USD Billion) and Forecast By End-User, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Injectable Contraceptives Market
14.1. Injectable Contraceptives MarketCompany Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Injectable Contraceptives Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Pfizer Inc.
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Billion), 2022
15.1.3.2. Pfizer Inc. 2022 Injectable Contraceptives Business Regional Distribution
15.1.4. Product/Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Bayer AG
15.3. Merck & Co., Inc.
15.4. Allergan PLC (acquired by AbbVie Inc. in 2020)
15.5. Teva Pharmaceutical Industries Ltd.
15.6. Agile Therapeutics
15.7. Novartis AG
15.8. Sun Pharmaceutical Industries Ltd.
15.9. Mylan N.V. (now part of Viatris Inc.)
15.10. TherapeuticsMD Inc.
15.11. Afaxys Inc.
15.12. Sinopharm Group Co., Ltd.
Frequently Asked Questions
What was the market size of the global injectable contraceptives in 2022?
The market size of injectable contraceptives was USD 3.5 Billion in 2022.
What is the CAGR of the global injectable contraceptives market from 2023 to 2032?
The CAGR of injectable contraceptives is 7.1% during the analysis period of 2023 to 2032.
Which are the key players in the injectable contraceptives market?
The key players operating in the global market are including Pfizer Inc., Bayer AG, Merck & Co., Inc., Allergan PLC, Teva Pharmaceutical Industries Ltd., Agile Therapeutics, Novartis AG, Sun Pharmaceutical Industries Ltd., Mylan N.V. (now part of Viatris Inc.), TherapeuticsMD Inc., Afaxys Inc., and Sinopharm Group Co., Ltd.
Which region dominated the global injectable contraceptives market share?
North America held the dominating position in injectable contraceptives industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of injectable contraceptives during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global injectable contraceptives industry?
The current trends and dynamics in the injectable contraceptives industry include high contraceptive efficacy and user convenience, and increasing awareness of family planning and reproductive health.
Which type held the maximum share in 2022?
The progesterone-only injectables type held the maximum share of the injectable contraceptives industry.
Select Licence Type
Connect with our sales team
Why Acumen Research and Consulting
100%
Customer Satisfaction
24x7+
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
